1. Henderson B. Arthritogenic actions of recombinant IL-1 and tumor necrosis factor α in the rabbit: evidence for synergistic interactions between cytokine in vivo. Clin Exp Immonol 1989;75:306–310.
2. Li SF. Levels and significance of TNF-α in peripheral blood and synovial fluid form patients with rheumatoid arthritis. Henan Med Res (Chin) 2007;16(1):59–60, 69.
3. Xie JM, Yu BY, Lu CS. Expression of vascular endothelial cell growth factor and its up-regulation of matrix metalioproteinase-2 activation in synovial fluid of patients with rheumatoid arthritis. Chin J Rheumatol (Chin) 2006;10:495–497.
4. Tang HH, Feng ZJ, Guo XH. Pathogenesis of IL-6 and TNF-α in the rheumatoid arthritis. Chin J Rheumatol (Chin) 1998;2:236–238.
5. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000;343:1594–1602.